COVID19 Research and Development Tracker: Vaccine rollouts, dosing controversies and new strains
Life Sciences Research & Analysis COVID19 Research and Development Tracker: Vaccine rollouts, dosing controversies and new strains 11 January...
Mr. Ando oversees the development of IHS Markit's global healthcare outlook analysis that focuses on market access, cost of healthcare and new treatment advances as well as coordinating its ongoing thinking on COVID-19. He heads the research and data teams that produce daily analysis, risk assessment and critical data for the pharmaceutical industry, as well as the consulting team that focuses on disease prevention, workforce and demand healthcare microsimulation models. With more than 15 years of experience in the industry, he is a regular speaker at conferences and is frequently cited by major media publications and national radio and television programs. He is the author and podium presenter of research at numerous academic conferences such as ISPOR. Mr Ando also oversees our global comparative industry group which provide critical long-term forecast perspectives across all industries around the world, as well as our specialised global constructrion group. Mr. Ando holds a postgraduate degree from the University of Uppsala, Sweden, and an undergraduate degree from the University of Durham in the United Kingdom.
Following the executive order on 13 September to l (...)
Join our IHS Markit experts, including Chief Econo (...)
While the COVID-19 virus will be with us throughou (...)